Please login to the form below

Not currently logged in
Email:
Password:

ABPI appoints new director of comms

Catherine Meaden was previously head of policy and public affairs at the body

ABPI,-Catherine-MeadenThe Association of the British Pharmaceutical Industry (ABPI) has named Catherine Meaden as its new director of communications.

Reporting to ABPI chief executive Stephen Whitehead, Meaden will lead the industry body's communications department, advise the senior leadership team and board of management on comms issues, and will be responsible for its engagement with government, NHS, media, patient groups and the broader healthcare community.

Before joining the ABPI in April 2012 as head of policy and public affairs, Meaden was associate director of marketing and communications at NHS Direct, notably during the swine flu pandemic. She has also worked in public affairs and campaigns at Cancer Research UK and the NHS Confederation.

“I am delighted by the appointment of Catherine as our new director of communications – her performance as our head of policy and public affairs was first rate and this appointment is thoroughly deserved,” Whitehead said.

“I look forward to working with Catherine as we continue to build a world class communications and advocacy function at the ABPI that speaks with a unified voice for the research based pharmaceutical industry.”

Commenting on her appointment, Meaden said: “To be appointed to this role, as the UK pharmaceutical industry faces so many challenges, is hugely exciting. I will be communicating to our partners and stakeholders the continuing problems our companies face in getting their medicines to patients whilst highlighting the huge contribution industry makes to the UK.”

Audrey Yvernault has replaced Meaden as head of policy and public affairs. She takes over this role having previously been head of CEO and president external affairs at the ABPI. Prior to this she was head of public affairs at outsourcing company VT Group, and external affairs adviser at AstraZeneca.

17th June 2013

From: Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
BOLDSCIENCE

We know what it takes to create brands, to start new conversations, to simply communicate complex science, to change lives…...

Latest intelligence

Personalised medicine AI
How early-stage clinical research is facilitating the new wave of personalised medicines
By Jorg Taubel...
patient diversity buckland
Patient diversity in clinical trials needs to be centre stage
By Danny Buckland...
Why empathy in digital patient recruitment is vital
This is where empathy mapping can be incredibly effective....